HIV Drug Descovy May Increase Risk of High Blood Pressure: Study
Kaiser Permanente researchers warn that the side effects of Descovy could result in an increased risk of hypertension and the need for cholesterol control.
Tag Archives: HIV
-
-
Appeals Court Weighs Gilead Challenge to Lawsuits Over Delaying HIV Drug Development
A California appeals court is weighing whether Gilead had a responsibility to develop safer HIV drugs to replace older ones with a higher risk of kidney damage and bone fractures.
-
U.S. Task Force Finds “High Benefit” from Use of HIV Drugs for Prevention
A federal task force is recommending widespread use of Gilead HIV drugs as preventative measures to those at high risk of exposure.
-
Lawsuit Over Atripla, Truvada Pay-to-Delay Generics Scheme Results in Defense Verdict for Gilead, Teva
Gilead and Teva are not liable for antitrust violations which insurers and other drug purchasers said was a "pay-to-delay" scheme designed to illegally maximize the manufacturers' profits.
-
Lawsuit Against Truvada, Viread Maker Alleges TDF-Based HIV Drugs Toxic to Users Kidneys, Bones
Nearly 20 plaintiffs have filed a lawsuit against Gilead, saying it failed to warn patients its TDF-based HIV drugs could cause bone and kidney problems.
-
Government’s Gilead HIV Drug Lawsuit Over Patent Rights Ends in Defense Verdict
A jury reached a defense verdict on Tuesday in a patent lawsuit filed by the U.S. government over Gilead's HIV drugs.
-
Gilead Faces Bone Demineralization Lawsuit Over Truvada, Other TDF-Based HIV Drugs
A lawsuit filed by two different plaintiffs say they suffered bone density loss due to the side effects of Gilead TDF-based HIV drugs.
-
Lawsuit Alleges Side Effects of Atripla, Stribild and Other HIV Drugs Endangered Patients to Increase Gilead Profits
A lawsuit filed by 20 plaintiffs claims Gilead held back safer formulations of its HIV drugs in order to maximize profits at the expense of their kidneys and other health…
-
Gilead HIV Drug Health Risks Were Known Before First TDF-Based Antiretrovirals Hit The Market: Lawsuit
Gilead knew its HIV drugs carried severe health risks before the first ones were placed on the market, the lawsuit claims.
-
HIV Drug Settlement Reached to Resolve Class Action Over Truvada, Stribild, Other Antiretrovirals
One drug manufacturer has agreed to pay $10 million to resolve its part in allegations that Gilead and other drug makers conspired to keep HIV medication prices artificially high.
